The FDA said it's taking action to protect patients from unapproved animal-derived thyroid medications and expressed concern over the use of unapproved GLP-1 receptor agonists for weight loss, such as ...

Texas Attorney General Ken Paxton on Tuesday sued U.S. drugmaker Eli Lilly for allegedly “bribing” providers to prescribe its ...

One popular health platforms is promoting GLP-1 microdosing for weight loss: But how safe and effective is this approach?

Texas Attorney General Ken Paxton on Thursday announced a lawsuit alleging that Eli Lilly (NYSE:LLY) bribed his state's medical providers in a bid to persuade them to prescribe the company’s weight ...

Discover Veru Inc.'s Q3 2025 earnings insights, including Phase III enobosarm trial updates, FDA feedback, and nondilutive funding plans for ...

Danone is launching Oikos Fusion, a dairy-based drink targeting U.S. consumers using weight loss medications like Wegovy.

Discover how GLP-1 medications and the MAHA movement are driving protein consumption and creating new opportunities for ...

Danone is said Oikos Fusion, which is launching in the US, was created “specifically with GLP-1 and weight loss consumers in mind.” ...

Data suggests that some sectors of Europe's confectionery sector are declining. Could GLP-1s have a role to play in this?

The rapid adoption of GLP-1 receptor agonists has fundamentally altered obesity management, with these medications now ...

Peptide therapeutics are rapidly emerging as a promising class of interventions for obesity, driven by growing insights into their ability to modulate key ...

Researchers suggest all diabetes patients on weight-loss drugs should be regularly screened and monitored for potential eye ...